Cerebral Hemodynamics During Early Verticalization After (Successful) Thrombectomy Poststroke
NCT ID: NCT04573114
Last Updated: 2021-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2020-09-02
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke subjects
Verticalization
Progressive levels of verticalization
Healthy
Verticalization
Progressive levels of verticalization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verticalization
Progressive levels of verticalization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≤12 hours after mechanical thrombectomy
* Conscious
* Hemodynamically stable
* 18 years or older
* Informed consent of the patient and/ or legal representative
Exclusion Criteria
* Known pre-stroke disease affecting cerebral blood flow
* Temporal bone windows insufficient to enable ultrasound penetration
* Intubation anticipated or occurred
* Venous thromboembolism
* Symptomatic intracranial hemorrhage
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Luft, MD
Role: STUDY_CHAIR
University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jeremia Held, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Deseoe J, Schwarz A, Pipping T, Lehmann A, Veerbeek JM, Luft AR, Wegener S, Globas C, Held JPO. Cerebral blood flow velocity progressively decreases with increasing levels of verticalization in healthy adults. A cross-sectional study with an observational design. Front Neurol. 2023 Apr 17;14:1149673. doi: 10.3389/fneur.2023.1149673. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-01732
Identifier Type: -
Identifier Source: org_study_id